Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,173.9
9.1 (0.29%)

 

  • STI Straits Times Index
    3,173.9
    9.1 (0.29%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,598.3
    5.8 (0.36%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,331.0
    368.4 (1.48%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,572.4
    14.1 (0.40%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,068.6
    517.7 (1.81%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,633.3
    7.2 (0.11%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,492.6M
  • Value: 1,237.8M
  • Rise: 199
  • Fall: 127
  • Unch: 425

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.079+0.009
Rex Intl0.310+0.005
Genting Sing0.795+0.015
Ntegrator Intl0.009-
Geo Energy Res0.410-0.010
RH PetroGas0.205-
Sembcorp Marine0.080-
MarcoPolo Marine0.028-0.001
BlackGoldNatural0.019-
ThaiBev0.715+0.005

World Indices

World Indices
Name Last Change
Nasdaq 14,897.3 +73.9
HSI 25,331.0 +368.4
HSCEI 8,966.2 +117.0
Jakarta 6,633.3 +7.2
Nikkei 225 29,068.6 +517.7
SSE Comp 3,572.4 +14.1
Shanghai A 3,743.9 +14.8
Shanghai B 278.0 +0.5
KOSPI 3,015.1 +26.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

SCPHARMACEUTICALS INC SCPHARMACEUTICALS
Updated on 15 Oct 2021 (End of trading day)
Last (USD): 6.590 Change: -0.140 High: 6.790 Remarks: -
Change (%): -2.08 Low: 6.320
Open 6.730 Yesterday's Close 6.7299999999999995
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 28,706 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.17742 Trailing EPS (USD) e -1.13272 NAV (USD) b 2.5239
PE a - Trailing PE f - Price / NAV b 2.6110
Dividend (USD) d - Cash In Hand (USD) g 2.7405 Issued & Paid-up Shares c 27,355,500
Dividend Yield (%) d - Price / Cash In Hand g 2.405 Treasury Shares h -
Market Cap (M) 180.273 Enterprise Value (M) 110.415
Piotroski F Score 1 Exchange Code SCPH Par Value ( $ ) n.a.
52 Weeks Volatility (%) 72.53 Free Float (%) 48.3
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 24 Mar 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 16 Nov 2017.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference SCPHARMACEUTICALS INC NASDAQ 180.273 - - 2.6110 -
Industry Pharmaceuticals: Major NASDAQ 2,306.550 86.908 91.614 3.3289 0.026
Local Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 186,577.819 58.379 49.477 11.9021 1.928
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 123,441.019 8.794 17.825 1.6460 2.738
Local Peer ROYALTY PHARMA PLC NASDAQ 23,309.333 23.906 23.992 4.0653 0.500
Local Peer VIATRIS INC NASDAQ 16,277.043 - - 0.7675 -
Local Peer REPLIGEN CORP NASDAQ 14,674.514 244.876 146.844 9.1540 -
Local Peer ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS NASDAQ 9,083.592 - - 11.1415 -
Local Peer CUREVAC NV NASDAQ 7,415.280 - - - -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 7,512.104 - - 22.0997 -
Local Peer ALLAKOS INC NASDAQ 5,803.544 - - 10.1641 -
Local Peer HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS NASDAQ 5,584.121 - - 5.6703 -
Local Peer I MAB SPON ADS EACH REP 2.3 ORD SHS NASDAQ 5,066.448 74.259 74.259 5.8881 -
Local Peer CEREVEL THERAPEUTICS HLDGS INC NASDAQ 5,116.808 - - 17.4110 -
Other Local Peers IMMUNITYBIO INC (NASDAQ), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), ERASCA INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), GENERATION BIO CO (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), PROCAPS GROUP S A (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), ICOSAVAX INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), KRONOS BIO INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), GH RESEARCH PLC (NASDAQ), TENAYA THERAPEUTICS INC (NASDAQ), ANNEXON INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), PETIQ INC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), VERU INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), BEYONDSPRING INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), PHARVARIS NV (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), GRITSTONE BIO INC (NASDAQ), AC IMMUNE SA (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), EVOLUS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), CLENE INC (NASDAQ), PYXIS ONCOLOGY INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), 89BIO INC (NASDAQ), ESSA PHARMA INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), ATHENEX INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), NEXIMMUNE INC (NASDAQ), XOMA CORP (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), DURECT CORP (NASDAQ), HARROW HEALTH INC (NASDAQ), VINCERX PHARMA INC (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), TRICIDA INC (NASDAQ), OBSEVA SA (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), IMMUNIC INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), MUSTANG BIO INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), ALZAMEND NEURO INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), POLYPID LTD (NASDAQ), NOVAN INC (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), EYENOVIA INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), GENPREX INC (NASDAQ), CLARUS THERAPEUTICS HLDGS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), IMARA INC (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), YUMANITY THERAPEUTICS INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), GALECTO INC (NASDAQ), PROPHASE LABS INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), GRAYBUG VISION INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), MANNATECH INC (NASDAQ), ABVC BIOPHARMA INC (NASDAQ), BONE BIOLOGICS CORP (NASDAQ), VIRPAX PHARMA INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), UNIVERSE PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), RENOVORX INC (NASDAQ), BAUDAX BIO INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), SEQLL INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), DERMATA THERAPEUTICS INC (NASDAQ), PASITHEA THERAPEUTICS CORP (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), XORTX THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), PAINREFORM LTD (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TELIGENT INC NEW (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), PETROS PHARMACEUTICALS INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 424,619.024 28.858 23.899 6.1026 2.467
Global Peer PFIZER INC NYSE 232,621.568 24.191 17.586 3.3212 3.662
Global Peer ELI LILLY AND COMPANY NYSE 227,551.488 36.739 37.484 35.3100 1.244
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 202,860.219 24.982 22.555 3.7538 2.313
Global Peer MERCK & CO INC NYSE 198,282.212 28.057 35.592 5.9555 3.165
Global Peer ABBVIE INC NYSE 193,205.789 42.407 29.322 15.3715 4.422
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 181,403.790 28.152 25.482 17.3508 1.314
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 129,682.340 - - 3.5232 3.184
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 98,144.089 13.313 16.547 4.6202 5.304
Global Peer WUXI APPTEC CO LTD HKEx 488,672.596 147.237 105.525 11.0692 0.213
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMACEUTICAL GROUP CO LTD (HKEx), INNOVENT BIOLOGICS INC (HKEx), CANSINO BIOLOGICS INC (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), ORGANON & CO (NYSE), SINOPHARM GROUP CO. LTD. (HKEx), REMEGEN CO LTD (HKEx), SHANGHAI PHARMACEUTICALS HOLDING CO (HKEx), HYGEIA HEALTHCARE HLDGS CO LTD (HKEx), HUTCHMED (CHINA) LIMITED (HKEx), SHANGHAI JUNSHI BIOSCIENCES CO LTD (HKEx), AKESO INC (HKEx), CHINA MEDICAL SYSTEM HLDGS LTD (HKEx), GUANGZHOU BAIYUNSHAN PHARMACEUTICAL (HKEx), INNOCARE PHARMA LTD (HKEx), CHINA RESOURCES PHARMACEUTICAL GR (HKEx), CARSGEN THERAPEUTICS HLDGS LTD (HKEx), CHINA GRAND PHARMACEUTICAL & HEALTH (HKEx), EMERGENT BIOSOLUTIONS INC (NYSE), SIMCERE PHARMACEUTICAL GRP LTD (HKEx), CHINA TRADITIONAL CHINESE MED HLDGS (HKEx), ADC THERAPEUTICS SA (NYSE), SHANGHAI HENLIUS BIOTECH INC (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), EVEREST MEDICINES LTD (HKEx), SHENZHEN HEPALINK PHARMACEUTICAL (HKEx), OCUMENSION THERAPEUTICS (HKEx), SSY GROUP LIMITED (HKEx), CSTONE PHARMACEUTICALS (HKEx), UNITED LABORATORIES INTL HLDGS LTD (HKEx), ZYMEWORKS INC (NYSE), ABBISKO CAYMAN LTD (HKEx), Kimia Farma Tbk. (IDX), BEIJING TONG REN TANG CHINESE MEDIC (HKEx), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), IMMUNOTECH BIOPHARM LTD (HKEx), SCICLONE PHARMACEUTICALS (HLDGS) LT (HKEx), ANTENGENE CORP LTD (HKEx), CK LIFE SCIENCES INTL HLDG (HKEx), TRANSCENTA HOLDING LTD (HKEx), CHINA SHINEWAY PHARMACEUTICAL GR (HKEx), HUA MEDICINE (HKEx), ZHAOKE OPHTHALMOLOGY LTD (HKEx), Soho Global Health Tbk. (IDX), IGBB (Bursa), STARPHARMA HOLDINGS LIMITED (ASX), RACE ONCOLOGY LTD (ASX), DAWNRAYS PHARMACEUTICAL HLDGS (HKEx), TOT BIOPHARM INTL CO LTD (HKEx), CYBIN INC (NYSE American), PYC THERAPEUTICS LIMITED (ASX), AFT PHARMACEUTICALS LTD (ASX), BSTEAD (Bursa), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), FUSEN PHARMACEUTICAL CO LTD (HKEx), PHARMA (Bursa), ANNOVIS BIO INC (NYSE American), IP (SET), CHINA BIOTECH SERVICES HLDGS LTD (HKEx), IX Biopharma (SGX), RECCE PHARMACEUTICALS LTD (ASX), ZHONGZHI PHARMACEUTICAL HLDGS LTD (HKEx), NOXOPHARM LTD (ASX), Merck Tbk. (IDX), LANNETT CO INC (NYSE), KOTRA (Bursa), CRESO PHARMA LTD (ASX), CHARMACY PHARMACEUTICAL CO LTD (HKEx), NEW RAY MEDICINE INTL HLDG LTD (HKEx), Phapros Tbk. (IDX), PAK FAH YEOW INTERNATIONAL (HKEx), SANAI HEALTH INDUSTRY GP CO LTD (HKEx), Hyphens Pharma (SGX), NOVA (Bursa), EXOPHARM LTD (ASX),